Inventor · disambiguated record
Ralph Lipp
Also filed as: LIPP RALPH · LIPP RALPH O
19 granted patents·18 pending applications·676 citations·filing 1986–2021
95Inventor score
Files withSCHERING AG17INST NAT SANTE RECH MED6HEIL WOLFGANG2BAYER IP GMBH1BAYER SCHERING PHARMA AG1
Top patents by PatentIndex Score
37 records- 0194US5676968ATransdermal therapeutic systems with crystallization inhibitorsSCHERING AG·Filed 1995·Granted Oct 14, 1997·162 cites·10 claims
- 0292US5904931ATransdermal therapeutic systems that contain sex steroids and dimethyl isosorbideSCHERING AG·Filed 1995·Granted May 18, 1999·149 cites·20 claims
- 0391US6787531B1Pharmaceutical composition for use as a contraceptiveSCHERING AG·Filed 2000·Granted Sep 7, 2004·70 cites·52 claims
- 0490US8715735B2Stabilised supersaturated solids of lipophilic drugsFUNKE ADRIAN·Filed 2005·Granted May 6, 2014·53 cites·17 claims
- 0586US4767778APharmaceutical compositions and methods for stimulating H3 histamine receptorsINST NAT SANTE RECH MED·Filed 1986·Granted Aug 30, 1988·42 cites·9 claims
- 0685US7569557B2Compositions of estrogen-cyclodextrin complexesBAYER SCHERING PHARMA AG·Filed 2006·Granted Aug 4, 2009·8 cites·16 claims
- 0783US5858394AAgent for transdermal administration that contains gestodene estersSCHERING AG·Filed 1994·Granted Jan 12, 1999·78 cites·15 claims
- 0880US7163931B2Compositions of estrogen-cyclodextrin complexesSCHERING AG·Filed 2005·Granted Jan 16, 2007·4 cites·52 claims
- 0976US6958326B2Cyclodextrin-drospirenone inclusion complexesSCHERING AG·Filed 2001·Granted Oct 25, 2005·8 cites·32 claims
- 1067US5559113AImidazole compounds and their therapeutic applicationsINST NAT SANTE RECH MED·Filed 1993·Granted Sep 24, 1996·20 cites·13 claims
- 1164US5399355AAgent for transdermal administration containing ergoline derivativesSCHERING AG·Filed 1993·Granted Mar 21, 1995·36 cites·13 claims
- 1263US2014050794A1Pharmaceutical composition for use as a contraceptiveBayer Pharma AG·Filed 2013·Application pending·0 cites
- 1362US6177416B1OxyiminopregnancarbolactonesSCHERING AG·Filed 1997·Granted Jan 23, 2001·17 cites·23 claims
- 1462US2010093679A1Drospirenone for hormone replacement therapyHEIL WOLFGANG·Filed 2009·Application pending·0 cites
- 1560US5034539AHistamine derivative, process for preparing it and its therapeutic useINST NAT SANTE RECH MED·Filed 1989·Granted Jul 23, 1991·8 cites·5 claims
- 1660US2006058272A1Pharmaceutical composition for use as a contraceptiveHILMAN JUERGEN·Filed 2005·Application pending·0 cites
- 1757US2003114429A1Pharmaceutical composition for use as a contraceptiveSCHERING AG·Filed 2003·Application pending·0 cites
- 1857US2003119798A1Pharmaceutical composition for use as a contraceptiveSCHERING AG·Filed 2003·Application pending·0 cites
- 1956US2021346416A1Pharmaceutical Compositions and Methods for their Use in Antiviral TherapyLIPP RALPH·Filed 2021·Application pending·0 cites
- 2053US2007087056A1Pharmaceutical form with sustained pH-independent active ingredient release for active ingredients having strong pH-dependent solubilityGUTHMANN CLAUDIA·Filed 2006·Application pending·0 cites
- 2151US2012220556A1Drospirenone for hormone replacement therapyHEIL WOLFGANG·Filed 2012·Application pending·0 cites
- 2250US5342960AAzomethines agonist compounds of the histamine H3 receptor for therapeutic use, pharmaceutical compositions acting as agonists of the said receptor and preparation processINST NAT SANTE RECH MED·Filed 1991·Granted Aug 30, 1994·8 cites·9 claims
- 2350US2004009960A1Drospirenone for hormone replacement therapySCHERING AG·Filed 2003·Application pending·0 cites
- 2450US2003144258A1Drospirenone for hormone replacement therapySCHERING AG·Filed 2003·Application pending·0 cites
- 2549US2003087913A1Solid pharmaceutical agent formulation for a piperazine urea derivativeSCHERING AG·Filed 2002·Application pending·0 cites
- 2649US2015182540A1Drospirenone for hormone replacement therapyBAYER IP GMBH·Filed 2015·Application pending·0 cites
- 2746US2002132801A1Drospirenone for hormone replacement therapySCHERING AG·Filed 2001·Application pending·0 cites
- 2846US2004081682A1Transdermal system (tds) that contain inhibitors of phosphodiesterase lVFiled 2001·Application pending·0 cites
- 2945US5708171AImidazole derivatives for pharmaceutical useINST NAT SANTE RECH MED·Filed 1996·Granted Jan 13, 1998·6 cites·14 claims
- 3043US2003157155A1Compositions for use as penetration promoters in transdermal formulations for highly lipophilic active ingredientsFiled 2001·Application pending·0 cites
- 3141USRE37303EImidazole compounds and their therapeutic applicationsINST NAT SANTE RECH MED·Filed 1993·Granted Jul 31, 2001·2 cites·13 claims
- 3241US2017014417A1Pharmaceutical administration system for the transdermal application of vardenafilLIPP LIFE SCIENCES LLC·Filed 2015·Application pending·0 cites
- 3340US2003003139A1Transdermal system that contains a new highly potent gestagenSCHERING AG·Filed 2001·Application pending·0 cites
- 3437US7148207B2Oral fludara of high-purity formulation with quick release of active ingredientSCHERING AG·Filed 2002·Granted Dec 12, 2006·0 cites·12 claims
- 3532US6156341ALow-dosed steroid tablets that contain gallic acid ester as an antioxidant, process for production, and useSCHERING AKTIENSGESELLSCHAFT·Filed 1995·Granted Dec 5, 2000·5 cites·10 claims
- 3627US2001009673A1Transdermal therapeutic systemsFiled 1997·Application pending·0 cites
- 3724US6512139B1Oxidation inhibitors in prostane derivativesSCHERING AG·Filed 1999·Granted Jan 28, 2003·0 cites·29 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →